<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81940">
  <stage>Registered</stage>
  <submitdate>29/03/2007</submitdate>
  <approvaldate>4/04/2007</approvaldate>
  <actrnumber>ACTRN12607000194460</actrnumber>
  <trial_identification>
    <studytitle>Assessment  of Diffraction Patterns  of Hair Fibres from Breast Cancer Patients using Synchrotron-Generated X-Ray</studytitle>
    <scientifictitle>To Determine the Accuracy of Assessment of Hair Fibres from Breast Cancer Patients using Synchrotron-Generated X-Ray Diffraction</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Ductal Carcinoma In-situ (DCIS)</healthcondition>
    <healthcondition>Early Breast Cancer (EBC)</healthcondition>
    <healthcondition>Metastatic Breast Cancer (MBC)</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Breast</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All participants at the time of enrolment will be asked to provide a sample of hair (approx. 10 hairs) cut from the back of their head and/or pubic region. A nurse will collect the hair using a sample holding card. The samples will then be sent to a synchrotoron for X-ray diffraction analysis.
The samples will be tested in batches when the synchrotron is available, each sample will be tested once, unless the result is inconclusive.</interventions>
    <comparator>No comparator.</comparator>
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To determine the accuracy of the x-ray diffraction test for breast cancer using hair.</outcome>
      <timepoint>The samples will be sent for testing once each group (DCIS, EBC and MBC) is completed (20 samples each).</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>There are no secondary objectives</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult women can participate if they  are willing and able to provide informed consent and have usable scalp and/or pubic hair. Women must have a diagnosis of DCIS, EBC or MBC.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Women are excluded if they have dyed or permed their scalp hair with the last six weeks and whose pubic hair is unavailable or women with a history of other cancers with the last five years.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>26/03/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fermiscan</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Fermiscan</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Examination of diffraction pattern in hair fibres from patients with breast cancer.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Prince Alfred Hospital-Sydney South West Area Health Service Ethics Review Committee(RPAH Zone)</ethicname>
      <ethicaddress />
      <ethicapprovaldate>14/02/2007</ethicapprovaldate>
      <hrec>X07-0035</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jane Beith</name>
      <address>Dept Medical Oncology
RPAH
Missenden Road
Camperdown NSW 2050</address>
      <phone>61 2 9515 8304</phone>
      <fax />
      <email>jane.beith@cs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jane Beith</name>
      <address>Dept Medical Oncology
RPAH
Missenden Road
Camperdown  NSW 2050</address>
      <phone>61 2 9515 8304</phone>
      <fax>61 2 9519 1546</fax>
      <email>jane.beith@cs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>